4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid
CAS : 153492-12-7
Ref. TR-D474250
1mg | Arrêté | ||
5mg | Arrêté | ||
2500µg | Arrêté |
Informations sur le produit
- 4-((Benzyloxy)(5-((tert-butoxycarbonyl)amino)pentyl)amino)-4-oxobutanoic Acid
Applications 4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid is an intermediate in synthesizing Deferoxamine-d7 TFA Salt (D228982), a labelled Deferoxamine Mesylate (D228980), which is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.
References Inati, A. et al.: Am. J. Hematol., 85, 782 (2010); Selim, M.: Translat. Stroke Res., 1, 35 (2010); Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2009)